Hamada S. Abulkhair

International Coastal Road
Damietta, DT, Egypt

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Pyridone-based EZH2 inhibitor anticancer candidates: synthetic approaches, comparative analysis, and future perspectives.

Pyridone-based EZH2 inhibitor anticancer candidates: synthetic approaches, comparative analysis, and future perspectives.

Journal: Future medicinal chemistry

Published: February 24, 2026

Rational design and synthesis of Co(ii), Ni(ii) and Cu(ii) complexes bearing 1,2,4-triazole scaffold for biological applications.

Rational design and synthesis of Co(ii), Ni(ii) and Cu(ii) complexes bearing 1,2,4-triazole scaffold for biological applications.

Journal: RSC advances

Published: December 04, 2025

α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives.

α-Glucosidase-targeting 1,2,4-triazole antidiabetic candidates: comparative analysis and future perspectives.

Journal: Future medicinal chemistry

Published: November 18, 2025

Therapeutic Horizons in Targeting EZH2 With Dual and Non-PROTAC Inhibitor Molecules: Recent Achievements, Comparative Analysis, and Future Perspectives.

Therapeutic Horizons in Targeting EZH2 With Dual and Non-PROTAC Inhibitor Molecules: Recent Achievements, Comparative Analysis, and Future Perspectives.

Journal: Archiv der Pharmazie

Published: November 10, 2025

From chemistry to targeted cancer therapy: potent benzimidazole-1,2,3-triazole hybrid-loaded nanogels against breast and colorectal malignancies.

From chemistry to targeted cancer therapy: potent benzimidazole-1,2,3-triazole hybrid-loaded nanogels against breast and colorectal malignancies.

Journal: RSC advances

Published: October 17, 2025

Therapeutic horizons in targeting XPO1 with small inhibitor molecules: Recent achievements, synthetic strategies, opportunities, challenges, and future perspectives.

Therapeutic horizons in targeting XPO1 with small inhibitor molecules: Recent achievements, synthetic strategies, opportunities, challenges, and future perspectives.

Journal: Bioorganic chemistry

Published: October 08, 2025

A bottomless well: 1,2,4-Triazoles continue to inspire scientific researchers to develop more and more anticancer molecules.

A bottomless well: 1,2,4-Triazoles continue to inspire scientific researchers to develop more and more anticancer molecules.

Journal: Bioorganic & medicinal chemistry

Published: June 19, 2025

A two-decade overview of oxadiazole derivatives as promising anticancer agents.

A two-decade overview of oxadiazole derivatives as promising anticancer agents.

Journal: RSC advances

Published: May 26, 2025

A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine-incorporating molecules.

A decade of research effort in synthesis, biological activity assessments, and mechanistic investigations of sulfamethazine-incorporating molecules.

Journal: Archiv der Pharmazie

Published: January 12, 2025

In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties.

In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties.

Journal: Future medicinal chemistry

Published: November 12, 2024

The role of the sulfaguanidine molecular scaffold in drug design and development.

The role of the sulfaguanidine molecular scaffold in drug design and development.

Journal: Archiv der Pharmazie

Published: October 10, 2024

Introducing the antibacterial and photocatalytic degradation potentials of biosynthesized chitosan, chitosan-ZnO, and chitosan-ZnO/PVP nanoparticles.

Introducing the antibacterial and photocatalytic degradation potentials of biosynthesized chitosan, chitosan-ZnO, and chitosan-ZnO/PVP nanoparticles.

Journal: Scientific reports

Published: May 07, 2024

Showing 1-12 of 48

Last Updated: 09/26/2026